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ABSTRACT  
Aims: Blood biochemistry may provide information on associations between road traffic noise, air 
pollution and cardiovascular disease risk. We evaluated this in two large European cohorts (HUNT3, 
Lifelines).     
Methods and Results: Road traffic noise exposure was modelled for 2009 using a simplified version 
of the Common Noise Assessment Methods in Europe (CNOSSOS-EU). Annual ambient air pollution 
(PM10, NO2) at residence was estimated for 2007 using a Land Use Regression model. The statistical 
platform DataSHIELD was used to pool data from 144,082 participants aged ≥20 years to enable 
individual-level analysis. Generalized linear models were fitted to assess cross-sectional associations 
between pollutants and high-sensitivity C-reactive protein (hsCRP), blood lipids and for (Lifelines 
only) fasting blood glucose, for samples taken during recruitment in 2006-2013.   
Pooling both cohorts, an interquartile range (IQR) higher day-time noise (5.1dB(A)) was associated 
with 1.1%(95%CI: 0.02%-2.2%) higher hsCRP, 0.7%(95%CI:0.3%-1.1%) higher triglycerides and 
0.5%(95%CI:0.3%-0.7%) higher high-density lipoprotein(HDL); only the association with HDL was 
robust to adjustment for air pollution. An IQR higher PM10 (2.0µg/m3) or NO2 (7.4µg/m3) was 
associated with higher triglycerides (1.9%, 95%CI:1.5%-2.4% and 2.2%, 95%CI:1.6%-2.7%), 
independent of adjustment for noise. Additionally for NO2, a significant association with hsCRP 
(1.9%, 95%CI: 0.5%-3.3%) was seen. In Lifelines, an IQR higher noise (4.2dB(A)) and PM10 
(2.4µg/m3) was associated with 0.2%(95%CI: 0.1%-0.3%) and 0.6%(95%CI:0.4%-0.7%) higher 
fasting glucose respectively, with both remaining robust to adjustment for air/noise pollution. 
Conclusion: Long-term exposures to road traffic noise and ambient air pollution were associated with 
blood biochemistry, providing a possible link between road traffic noise/air pollution and cardio-
metabolic disease risk.  
Keywords: traffic noise, air pollution, systemic inflammation, blood lipids, blood glucose 
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Translational Perspective  
Road traffic noise and air pollution are the two most common environmental stressors and both have 
been associated with cardiovascular disease in a growing number of studies. Evidence for the long-
term effects of both pollutants on traditional cardiovascular risk factors is limited. Our results based 
on two large European population-based cohorts suggest that both road traffic noise and ambient air 
pollution may increase systemic inflammation, blood glucose levels and risk for potential lipid 
disturbance. Our findings highlight the importance to consider environmental causes in the prevention 
and pathogenesis of cardiovascular disease and the collective efforts needed to mitigate noise and air 
pollution.   
4 
 
Introduction 
Increasing numbers of studies have suggested that long-term exposure to road traffic noise(1) and 
ambient air pollution(2) have been linked to cardiovascular disease (CVD) morbidity and mortality 
via different but not mutually exclusive hypothesised mechanistic pathways(3).     
As proposed by Babisch(4), traffic noise as an environmental stressor exerts adverse health effects via 
both direct (e.g. sleep disturbance) and indirect (e.g. annoyance) pathways. Based on the stress 
reaction model, both pathways lead to a physiologic acute response, for example, elevated levels of 
stress hormones, through activations of the hypothalamus-pituitary-adrenal axis and the sympathetic-
adrenal-medulla axis(3). In the long-term, stress hormone such as cortisol is overly produced to 
restore homeostasis partly by increasing the supply of energy in the forms of glucose and fatty 
acids(5,6). Catecholamines are an important stress hormone to boost this supply by breaking down 
triacylglycerol(5). In addition, overproduction of cortisol is also believed to inhibit insulin secretion as 
well as to impair insulin sensitivity in both the liver and adipose tissue(6). For air pollution, oxidative 
stress is the principal hypothesised mechanism to explain the adverse health effects, with other 
pathways including impaired endothelial function, systemic inflammation, activation of autonomous 
nervous system (ANS) and direct transfer of particles from lung to blood circulation also 
contributing(2).  
It is biologically plausible to hypothesise that via these aforementioned mechanistic pathways both 
long-term noise and air pollution exposures may lead to adverse changes in CVD risk factors 
including systemic inflammation, blood lipids and glucose(2-4), thus mediating the links between 
these exposures and manifest CVD. However, epidemiological evidence linking these exposures, 
especially noise, with CVD risk factors is rather limited(3,7). Noise could also be a potential 
confounder in any associations between air pollution and CVD risk factors, which merits further 
investigation(7).          
We evaluated cross-sectional associations between long-term road traffic noise, ambient air pollution 
and high sensitivity C-reactive protein (hsCRP), blood lipids and glucose levels in two large European 
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cohorts. Harmonised exposure and health data were analysed at the individual-level via 
DataSHIELD(8), a novel statistical platform that allows pooling of data via distributed data analysis.      
Methods 
Study populations  
Two cohorts, HUNT3(9) and Lifelines(10), were included in this study as part of the BioSHaRE 
(Biobank Standardisation and Harmonisation for Research Excellence in the European Union-
BioSHaRE-EU) project.   
The HUNT (Helseundersøkelsen i Nord-Trøndelag) study is a population-based health survey 
conducted in the county of Nord-Trøndelag in central Norway, targeting all residents aged≥20 
years(9). We used data from the third survey (HUNT3) undertaken in 2006-2008, during which 
50,805 residents participated and provided data, all of whom were included in our study.  
Lifelines is a prospective multi-generational population-based cohort study to examine the health and 
health-related behaviours of people living in northern Netherlands(10). Compared to those of the 
HUNT study, study areas of Lifelines are more densely populated(11). During baseline recruitment 
(2006-2013), a random selection of residents aged 25-50 years and their family members registered in 
general practices were invited to participate. Quality-checked data from 93,277 participants were 
available for analysis by the time our study was conducted. 
Ethical approvals for this study were obtained from the Regional Committee for Medical and Health 
Research Ethics in Norway for HUNT and from the Medical Ethical Committee of the University 
Medical Center Groningen for Lifelines.   
Biochemistry data  
Details of the collection, transport, storage and analysis of the blood samples in each cohort have been 
published(9,10). In brief, for both cohorts, blood samples were collected and transported on the same 
day, and were stored at -80°C for future analysis. Non-fasting blood samples were collected in 
HUNT3 whilst fasting blood samples were collected in Lifelines. Samples were analysed in a central 
laboratory for each cohort, following respective quality control measures.   
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Serum concentrations of hsCRP (mg/L), total cholesterol (mmol/L), triglycerides (mmol/L), and high-
density lipoprotein (HDL) cholesterol (mmol/L) were measured in both cohorts. Additionally for 
Lifelines, fasting blood glucose (mmol/L) and glycated haemoglobin (HbA1c) concentrations 
(mmol/mol) were also measured.   
Exposure assessment  
A simplified version of the CNOSSOS-EU (Common noise assessment methods in European Union) 
noise modelling framework(12) was developed and run for each cohort. Noise sound pressure level 
was estimated on all roads within 500 meters of home address at recruitment. Noise propagation due 
to refraction and diffraction, absorption from buildings, distance and angle of view were considered in 
the model. Road network geography, calculated hourly vehicle flows using a daily average traffic 
profile, building heights, land cover and meteorological data were obtained for the respective study 
areas. To account for participants living on minor roads that were not captured in the national level 
traffic datasets, a fixed low-level baseline traffic flow (600 vehicles per day) was assigned. Traffic 
data were for the year 2009 and land cover data were for the year 2006. Annual mean A-weighted 
sound pressure level in decibels (dB(A)) for day-time noise (average sound level from 07:00 to 19:00) 
and night-time noise (average sound level from 23:00 to 07:00) and weighted 24-hour noise (Lden) 
were modelled at recruitment address of participants in both cohorts.   
An European harmonised Land Use Regression (LUR) model at a resolution of 100x100m was used 
to assign annual air pollution estimates, PM10 (Particulate Matter with aerodynamic diameter≤10µm) 
and NO2 (nitrogen dioxide), for year 2007 at participant’s recruitment address(13). The model used 
information from over 1,500 monitoring sites across western Europe, satellite-based ground-level air 
pollution data and land use variables obtained from a Geographic Information System (GIS)(13).        
Covariates 
Age, sex, smoking status, smoking pack-years, education, paid employment, alcohol consumption and 
‘ever-had’ hypertension and diabetes were obtained from questionnaires at recruitment. Height (cm) 
and weight (kg) were measured after removal of heavy clothes and shoes and body mass index (BMI, 
kg/m2) was computed. Time at residence of recruitment in years was calculated for each participant. 
Season of blood draw was based on the calendar month the participant attended for clinical 
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measurements. All these covariates were retrospectively harmonised across the two cohorts, following 
a validated protocol(14).   
Statistical analyses  
Statistical analyses for hsCRP and blood lipids were performed using DataSHIELD v4.1.2(8). In 
brief, the DataSHIELD approach involves setting up secure servers hosting harmonised data in 
geographically dispersed research sites (e.g. Groningen for Lifelines and London for HUNT3) and 
allowing a central computer to conduct remote federated analyses of individual-level data without 
physically pooling this data. DataSHIELD offers an effective solution to overcome the complex 
ethico-legal issues associated with a physical sharing of the data. Analyses on fasting blood glucose 
and HbA1c were conducted in Lifelines only also using DataSHIELD in ‘single-site’ mode which 
provides, in effect, a privacy-protected analysis in an R statistical environment.  
All outcomes were modelled as a log-transformed value to improve linearity and results were 
expressed as percent change per inter-quartile range (IQR) higher exposure. 
Spearman correlations between metrics of road traffic noise and ambient air pollution were calculated 
for each cohort. Associations between the noise, PM10, NO2 and each biochemical parameter were 
analysed using multivariate linear regression. Both noise and air pollution metrics were analysed on a 
continuous scale, assuming a linear effect. Additionally noise was categorised as <55, 55-60, ≥60 
dB(A) for daytime and <45, 45-50, ≥50 dB(A) for night-time noise respectively.   
The covariates were chosen a priori based on current knowledge. The sequence of models was as 
follows: adjusted for study (in pooled analyses on hsCRP and blood lipids), age (continuous) and sex 
(Model1), further adjusted for season of blood draw, smoking status and pack-years, education, 
employment and alcohol consumption (Model2). Based on Model2, ambient air pollution (or road 
traffic noise) were additionally added to the noise (or air pollution) model (mutually adjusted 
model).  
Sensitivity analyses were conducted based on Model2: a) further adjusting for BMI; b) further 
adjusting for ever-had hypertension and diabetes; c) restricting analyses to those living at current 
address≥10 years; d) as with a previous study(15), excluding those with an hsCRP over 10 mg/ L 
from the analysis as levels above this may indicate a current infection.   
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We also conducted study-specific analyses for hsCRP and blood lipids and then pooled estimates via 
meta-analysis using R ‘metafor’ packages v3.2.2.  
Results 
Overall there were 144,082 participants, mean age (SD) was 47.6 (13.7) years, and 56% (n=82,574) 
were women (Table1).   
Across the two cohorts, median Lday was 51.6 dB(A), with an IQR of 5.1 dB(A); median PM10 and 
NO2 were 18.8 and 17.2 µg/m3, with an IQR of 2.0 and 7.4 µg/m3 respectively (Supplement-1). 
Spearman correlations between PM10 and Lday was 0.04 (HUNT3) and 0.38 (Lifelines); similar 
correlations were seen for NO2. Daytime and night-time noise or 24-hour noise were almost perfectly 
correlated (r=0.99). We therefore report only results for daytime noise here.     
In the pooled analyses of both HUNT3 and Lifelines, an IQR increase in daytime noise, PM10 and 
NO2 was significantly associated with higher levels of hsCRP (Table 2) in the fully adjusted model 
(Model2), but significance only remained for NO2 (1.7%, 95% confidence interval (CI): 0.2%-3.2%) 
in the model further adjusted for noise (mutually adjusted model).  
An IQR increase in daytime noise, PM10 and NO2 was significantly associated with 0.7% 
(95%CI:0.3%-1.1%), 1.9% (95%CI:1.5%-2.4%) and 2.2% (95%CI:1.6%-2.7%) higher levels of 
triglycerides respectively (Table 3).  However, when Model 2 was mutually adjusted for both noise 
and air pollution, significance remained for both air pollutants, but not noise. We found no 
associations between any of the exposures and total cholesterol (Supplement-2), but significant 
positive associations between noise or NO2 and HDL cholesterol were observed(Table 3).   
In the analyses of fasting glucose in Lifelines only(Table 4), an IQR increase in daytime noise, PM10 
and NO2 was significantly associated with 0.2% (95%CI:0.1%-0.3%), 0.6% (95%CI:0.4%-0.7%) and 
0.6% (95%CI:0.4%-0.8%) higher levels of fasting glucose respectively. These significant associations 
remained in the mutually adjusted models. Corresponding associations were not seen for HbA1c 
(Supplement-2).  
Sensitivity analyses only resulted in minor changes to the main findings described for each 
biochemistry parameter, except that the significant positive associations between air pollution and 
9 
 
HDL cholesterol were no longer seen after further adjustment for BMI (supplement-3). Treating noise 
as a categorical variable in Model2 showed that for hsCRP, triglycerides and fasting glucose, 
significant associations were only observed among those with a day-time noise level ≥60 vs. <50 
dB(A) (supplement-4).   
Study-specific meta-analyses for hsCRP and blood lipids yielded similar results to the pooled analyses 
on DataSHIELD (Supplement-5).   
Discussion 
In this large population-based study, we found that higher long-term road traffic noise was 
significantly associated with higher levels of hsCRP, triglycerides, HDL cholesterol and fasting 
glucose, with the latter two associations remaining after further adjustment for air pollution. Higher 
PM10 or NO2 exposure was significantly associated with higher levels of triglycerides and fasting 
glucose, independent of road traffic noise. Both air pollutants were also significantly associated with 
higher hsCRP levels, but the significance for PM10 was lost after adjustment for traffic noise.  
Road traffic noise effects  
There have been very few studies investigating the effects of road traffic noise on cardiovascular risk 
factors to date. Chronic noise exposure may trigger the same responses (e.g. oxidative stress, systemic 
inflammation) as air pollutants(6) and it has been suggested that the link between long-term 
psychological stress and CVD may operate via a chronic low-grade systemic inflammation(16). We 
are not aware of any other studies exploring the association between road traffic noise and hsCRP. We 
observed a small increase in hsCRP levels in relation to noise exposure when assessed as a continuous 
variable. Analysing noise as a categorical variable suggested that there may exist a threshold of 60 
dB(A), above which a significant positive association on hsCRP was seen in our study. However, 
significance was lost after adjustment for air pollution.   
The over-production of stress hormones (e.g. catecholamines) following long-term noise exposure is 
believed to increase the supply of fatty acids and glucose by breaking down triacylglycerol(5). In 
support of this hypothesised mechanism, we found significant positive associations between road 
traffic noise exposure and triglycerides. Only one population-based study was conducted previously 
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and reported no association with total cholesterol(17). In our study, we found no associations with 
total cholesterol either, but a positive significant association was unexpectedly found with HDL 
cholesterol. There is no biological plausible explanation for this association and it is possible that this 
is a chance finding due to multiple testing. Findings across a small number of occupational studies 
were not consistent with regards to which lipids were adversely affected by noise exposures(18). The 
role of traffic noise in the perturbations in lipid levels is rarely investigated(3) and our findings should 
be interpreted with caution until further studies have confirmed this result.     
Our study provides novel evidence that increasing road traffic noise is associated with increasing 
fasting blood glucose levels, independent of air pollution effects. Only one study in the early 1990s 
reported a positive trend (p-value<0.05) between higher day-time noise level and increased glucose 
level in men(19). Another study in Stockholm found no associations between aircraft noise exposure 
and impaired fasting glucose(20). In a Danish prospective cohort, a 10dB higher road traffic noise at 
diagnosis was associated with a 8% (95%CI: 2%-14%) higher risk of incident diabetes, after 
adjustment for air pollution(21).   
Air pollution effects 
An inflammatory response to ambient air pollution has been perceived as one of the key mechanisms 
that may explain air pollution effects on CVD(2). Our findings on elevated hsCRP for both air 
pollutants generally support this concept. An analysis of 22,561 adults from six European cohorts 
observed a significant association between elevated hsCRP levels and living close to traffic but not for 
modelled air pollutants(15). A longitudinal analysis with repeated measurements of hsCRP in 
Germany found that each IQR (2.4µg/m3) higher PM2.5 was associated with 5.4% (95%CI: 0.6%- 
10.5%) higher hsCRP, independent of short-term air pollution(22). Two other studies in England(23) 
and Sweden(24) reported no associations with hsCRP.     
Inflammation-induced adverse lipid metabolism and lipid oxidation may be among the possible 
mechanisms underlying the associations between air pollution and perturbations in lipid levels(25). A 
study of nearly 40,000 adults aged 50-64 years in Copenhagen reported that both PM2.5 and NO2 were 
significantly associated with elevated non-fasting total cholesterol(17). Data on other lipid measures 
were not available. Similarly, a nationwide USA study of 11,623 participants (median age: 41 years) 
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reported significant positive associations between annual PM10 exposure and both triglycerides and 
total cholesterol levels(25). Association with HDL cholesterol was positive but non-significant. Partly 
in line with this, we found both higher PM10 and NO2 were significantly associated not only with 
elevated triglycerides but also HDL cholesterol levels, although for the latter the association was non-
significant after further adjustment for BMI.   
Air pollution may also affect glucose homeostasis via pathways including increased adipose tissue 
inflammation and oxidative stress as well as impaired insulin responses in the liver and adipose 
tissue(3). Our findings of significant associations with fasting glucose for long-term PM10 and NO2 
exposures were partly consistent with previous studies of various designs(26-29). However, we did 
not observe an association with HbA1c. Annual average of PM10 and NO2 was significantly 
associated with increased fasting glucose and HbA1c among elderly participants in Taiwan(26) while 
in Germany higher regional PM10 levels were significantly associated with higher HbA1c levels 
among patients with diabetes(28). A study of 363 elderly German women reported that long-term 
exposure to NO2 may contribute to impaired glucose metabolism, although significance was lost after 
correction for multiple testing(27). Recently, a nationwide cross-sectional study of 11,847 adults in 
China observed that satellite-based modelled annual PM2.5 at residence was significantly associated 
with both increased fasting glucose and HbA1c(29).   
Strengths and limitations  
Strengths include our ability to simultaneously examine the effects of noise and air pollution exposure 
on cardiovascular risk factors in this large sample. In addition, data across the two cohorts were 
harmonised and then individual-level analyses and data pooling were carried out via DataSHIELD, 
making this one of the largest such studies to date. The novel use of DataSHIELD was validated 
through meta-analysis of the two cohorts involved, with DataSHIELD giving similar effect estimates 
but (as expected) smaller confidence intervals as individual participant data were analysed together.  
Limitations include the cross-sectional nature of the study, longitudinal studies are needed to 
strengthen these findings. Modelled noise and air pollution estimates at home address will inevitably 
have some misclassification (e.g. time spent away from home). However, this was likely non-
differential with regard to biochemistry measurements. Correlations between PM10 and NO2 were high 
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which precluded a co-pollutant analysis. Some simplified inputs were used in our noise model to 
enable a harmonised approach across the two cohorts investigated(30); this may have resulted in non-
differential misclassification of noise exposure that would be expected to bias results toward the null. 
The European harmonised LUR model for air pollution was likely less accurate for the HUNT cohort 
for two reasons. First, no Norwegian monitoring air pollution data were used in the model building 
and therefore the performance of this LUR model cannot be formally measured in Norway. However, 
the use of this LUR model for the HUNT cohort was reasonably justified based on the model’s 
moderate to good performance in other Scandinavian countries. Second, the road networks used in the 
air pollution/noise models building for the Netherlands had a more complete representation of both 
major and minor roads whilst for Norway the road networks only had major roads included. 
Therefore, the relatively low correlation between noise and air pollution seen for the HUNT cohort 
may be driven in part by the less detailed data inputs. While road traffic is a major source of both 
noise and air pollutants, these variables are not always closely correlated(31). Noise and air pollution 
estimates at recruitment address were modelled to a single year 2009 and 2007 respectively, which 
may differ by several years from when recruitment took place in both cohorts (2006-2013). We made 
a reasonable assumption that the spatial contrast in levels of both exposures will have been relatively 
stable over these years. Estimates may have residual confounding, as information about 
environmental tobacco smoke, diet, exercise and area-level socioeconomic status were not 
harmonised and therefore were not included in our models. Finally, we used nominal P-values, so 
given the number of tests it is possible that some observed associations may be chance findings; 
replication in other studies is therefore recommended.  
In our study, the observed effects of road traffic noise and air pollution on CVD risk factors are small 
and potentially within the precision of a laboratory measurement for an individual. The clinical impact 
of an increase in risk of that magnitude on any individual would be very small if not negligible, 
despite statistical significance. However, the importance of these population-based results is that they 
suggest that the entire distribution of these risk factors may be shifted towards a less favourable 
profile at population level, i.e. ‘at-risk’ populations may be increased. Our results contribute to the 
evidence base to identify potential mechanisms and quantify impacts of both road noise and air 
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pollution exposures on cardiovascular disease at population level. Future work will explore potential 
for effect modification and whether effects are confined to a subset of the population.  
In conclusion, we found significant associations of long-term exposure to road traffic noise and 
ambient air pollution with CVD biochemical parameters, providing a possible link between noise or 
air pollution exposure and cardiovascular disease.  
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Table 1 Characteristics of study populations in both cohorts  
  Pooled data HUNT3 Lifelines 
Total N 144,082 50,805 93,277 
Age, years, mean±SD 47.6±13.7 52.7±16.7 44.9±12.3 
Sex, women, (%) 56 55 59 
BMI, kg/m2, mean±SD 26.5±4.4 27.2±4.4 26.1±4.3 
BMI categories, (%)       
<25 kg/m2 41 33 45 
25-30 kg/m2 41 44 39 
≥30 kg/m2 18 23 16 
Smoking status, (%)       
Never-smoker 44 43 45 
Ex-smoker 32 32 32 
Current-smoker 24 25 23 
Current working status, (%)       
Not in paid employment 25 36 19 
In paid employment 75 64 81 
Education level, (%)       
primary education or less 11 31 2 
Secondary education 62 47 68 
Post-secondary school or above 28 22 30 
Ever-had diabetes 3 4 2 
Ever-had hypertension 24 22 25 
Alcohol consumption, gram per 
week, mean±SD 
31.6±88.8 28.0±40.0 56.9±71.5 
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
hsCRP, mg/L, median±IQR 1.2±2.1 1.2±2.1 1.2±2.2 
Total cholesterol, mmol/L, 
mean±SD 
5.2±1.0 5.5±1.1 5.0±1.0 
HDL cholesterol, mmol/L, 
mean±SD 
1.4±0.4 1.4±0.3 1.5±0.4 
Triglycerides, mmol/L, mean±SD 1.3±0.9 1.6±1.0 1.1±0.8 
Fasting glucose, mmol/L, 
mean±SD 
- - 5.0±0.8 
HbA1c, mmol/mol, mean±SD - - 37.5±4.8 
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Table 2  Cross-sectional associations between per IQR higher exposure and hsCRP: pooled analyses 
from HUNT3 and Lifelines  
  %changes (95%CI) in hsCRP  
Exposure IQR N Model1 N Model2 Model2* 
Daytime 
noise 
5.1dB(A) 90,689 0.4  
(0.1-0.8) 
55,930 1.1  
(0.02-2.2) 
1.0  
(-0.1-2.2)a 
      0.9  
(-0.3-2.0)b 
PM10 2.0µg/m3 87,622 1.3  
(0.2-2.4) 
51,238 1.4  
(0.1-2.7) 
0.9  
(-0.4-2.3) 
NO2 7.4µg/m3 87,957 1.0  
(-0.1-2.2) 
51,459 1.9  
(0.5-3.3) 
1.7  
(0.2-3.2) 
Model 1: adjusted for cohort, age, sex; 
Model 2: further adjusted for season of blood draw, smoking status and pack-years, education, employment and 
alcohol consumption.  
Model 2*: further adjusted for air pollution (a for PM10, b for NO2), or daytime noise, based on Model 2.  
BOLD indicates where significance level <0.05.  
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Table 3 Cross-sectional associations between per IQR higher exposure and triglycerides and HDL 
cholesterol: pooled analyses from HUNT3 and Lifelines  
  %changes (95%CI) in triglycerides   
Exposure IQR N Model1 N Model2 Model2* 
Daytime noise 5.1dB(A) 119,464 0.7  
(0.4-1.0) 
81,799 0.7  
(0.3-1.1) 
0.2  
(-0.2-0.7)a 
      0.3  
(-0.2-0.7)b 
PM10 2.0µg/m3 111,547 1.4 
(1.0-1.8) 
72,794 1.9 
(1.5-2.4) 
1.9 
(1.4-2.4) 
NO2 7.4µg/m3 111,893 1.6 
(1.1-2.0) 
73,026 2.2 
(1.6-2.7) 
2.1 
(1.6-2.7) 
       
  %changes (95%CI) in HDL cholesterol   
Exposure IQR N Model1 N Model2 Model2* 
Daytime noise 5.1dB(A) 118,866 0.3  
(0.2-0.5) 
81,590 0.5 
(0.3-0.7) 
0.4 
(0.1-0.6)a 
      0.3 
(0.04-0.5)b 
PM10 2.0µg/m3 110,834 0.1 
(0.04-0.2) 
72,551 0.2 
(-0.1-0.4) 
0.04 
(-0.2-0.3) 
NO2 7.4µg/m3 111,178 0.4 
(0.2-0.7) 
72,783 0.5 
(0.3-0.8) 
0.4 
(0.1-0.7) 
Model 1: adjusted for cohort, age, sex  
Model 2: further adjusted for season of blood draw, smoking status and pack-years, education, employment and 
alcohol consumption.  
Model 2*: further adjusted for air pollution (a for PM10, b for NO2), or daytime noise, based on Model 2.  
BOLD indicates where significance level <0.05.   
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Table 4 Cross-sectional associations between per IQR higher exposure and fasting glucose: analyses 
of Lifelines cohort  
  %changes (95%CI) in fasting glucose  
Exposure IQR N Model1 N Model2 Model2* 
Daytime 
noise 
4.2dB(A) 72,401 0.2 
(0.1-0.3) 
62,765 0.2 
(0.1-0.3) 
0.2 
(0.06-0.3)a 
      0.1 
(0.03-0.3)b 
PM10 2.4µg/m3 59,898 0.5 
(0.4-0.7) 
52,234 0.6 
(0.4-0.7) 
0.5 
(0.3-0.6) 
NO2 8.8µg/m3 60,182 0.5 
(0.4-0.7) 
52,543 0.6 
(0.4-0.8) 
0.5  
(0.3-0.7) 
Model 1: adjusted for age, sex  
Model 2: further adjusted for season of blood draw, smoking status and pack-years, education, employment and 
alcohol consumption.  
Model 2*: further adjusted for air pollution (a for PM10, b for NO2), or daytime noise, based on Model 2.  
BOLD indicates where significance level <0.05.   
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Figure legends  
 
Figure 1. Cross-sectional associations between per IQR* higher exposure and percent changes in each CVD biochemical parameter   
 
Model 2: adjusted for cohort (pooled analysis only), age, sex, season of blood draw, smoking status and pack-years, education, employment and alcohol consumption.  Model 2*: further 
adjusted for PM10 or daytime noise. *IQR: Inter-quartile range, which is 5.1 dB(A) for daytime noise, 2.0 µg/m3 for PM10, 7.4µg/m3 for NO2 for analyses on hsCRP and lipids; 4.2 dB(A) for 
daytime noise, 2.4 µg/m3 for PM10, 8.8 µg/m3 for NO2 for analyses on blood glucose.  
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Supplement-1  
 
Table S1.1: Distributions of exposures in this study by cohort and in the pooled data  
 
NO2, µg/m3 N 5% 10% 25% 50% 75% 90% 95% Mean(SD) IQR 
HUNT3 50,628 8.2 8.8 10.1 11.9 15.4 18.6 19.5 13.0 (3.9) 5.3 
Lifelines 62,212 13.6 14.1 16.6 20.6 25.4 28.9 31.1 21.2 (5.7) 8.8 
Pooled 112,840 11.5 12.1 14.1 17.2 21.5 24.9 26.6 18.0 (5.1) 7.4 
PM10,µg/m3 N 5% 10% 25% 50% 75% 90% 95% Mean(SD) IQR 
HUNT3 50,567 9.7 10 10.4 11.2 12 12.6 12.9 11.3 (1.1) 1.6 
Lifelines 61,927 21 21.4 22.3 23.6 24.7 25.7 26.5 23.6 (1.7) 2.4 
Pooled 112,494 16.6 17.0 17.7 18.8 19.7 20.6 21.2 18.8 (1.5) 2.0 
Daytime 
noise(Lday) 
N 5% 10% 25% 50% 75% 90% 95% Mean(SD) IQR 
HUNT3 45,644 39.1 39.5 43.6 47.4 50.3 52.9 54.6 47.0 (4.9) 6.7 
Lifelines 74,744 51.3 51.7 52.4 53.9 56.6 60.4 63.9 55.2 (4.0) 4.2 
Pooled 120,388 47.0 47.3 49.3 51.6 54.4 57.7 60.6 52.3 (4.3) 5.1 
Nighttime 
noise(lnight) 
N 5% 10% 25% 50% 75% 90% 95% Mean(SD) IQR 
HUNT3 45,644 35.1 35.2 37.5 40.2 42.5 44.8 46.4 40.3 (3.7) 5.0 
Lifelines 74,744 42.5 42.8 43.6 45.1 47.8 51.6 55.1 46.4 (4.0) 4.2 
Pooled 120,388 39.8 40.1 41.5 43.4 45.9 49.2 52.0 44.2 (3.9) 4.4 
NO2 and PM10 were estimated based on the pan-European LUR model for year 2007 while noise estimates (Lday and Lnight) were for year 2
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Table S1.2: Spearman correlations between air pollutants and road traffic noise (Lday and 
Lnight)  
 
HUNT3 (N=45,581) NO2 PM10 LDAY 
NO2 -   
PM10 0.80 -  
Lday -0.05 0.04 - 
Lnight -0.04 0.06 0.99 
Lifelines (N=62,653) NO2 PM10 LDAY 
NO2 -   
PM10 0.78 -  
Lday 0.43 0.38 - 
Lnight 0.46 0.40 0.99 
 Lday: day-time noise level at 07:00-19:00; Lnight: night-time noise level at 23:00-07:00.   
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Table S2.1 Cross-sectional analyses between daytime noise, air pollution and cholesterol: pooled 
analyses of HUNT3 and Lifelines  
 
 %changes (95%CI) in total cholesterol   
Exposure IQR N Model1 N Model2 Model2* 
Daytime 
noise 
5.1dB(A
) 
118,8
68 
-0.1 (-0.2 to 0.02) 81,5
90 
-0.1 (-0.2 to 0.1) 0.03 (-0.1 to 
0.2)a 
      0.01 (-0.2 to 
0.2)b 
PM10 2.0µg/m
3 
110,8
36 
-0.5 (-0.6 to -0.3) 72,5
51 
-0.1 (-0.3 to 
0.05) 
-0.1 (-0.3 to 
0.06) 
NO2 7.4µg/m
3 
111,1
80 
-0.4 (-0.6 to -0.2) 72,7
83 
-0.1 (-0.3 to 0.1) -0.1 (-0.3 to 0.2) 
Model 1: adjusted for cohort, age, sex; 
Model 2: further adjusted for season of blood draw, smoking status and pack-years, education, employment and alcohol consumption.  
Model 2*: further adjusted for air pollution (a for PM10, b for NO2), or daytime noise, based on Model 2.  
BOLD indicates where significance level <0.05.  
 
Table S2.2 Cross-sectional analyses between daytime noise, air pollution and HbA1c: analyses 
of Lifelines  
  %changes (95%CI) in HbA1c   
Exposure IQR N Model1 N Model2 Model2* 
Daytime 
noise 
4.2dB(A) 56,0
26 
-0.1 (-0.1 to 0.04) 50,1
94 
-0.1(-0.1 to 0.05) -0.1 (-0.1 to 
0.08)a 
      0.01 (-0.1 to 0.1)b 
PM10 2.4µg/m
3 47,6
28 
-0.1 (-0.1 to 0.1) 43,4
81 
-0.1(-0.2 to 0.1) -0.1 (-0.2 to 0.1) 
NO2 8.8µg/m
3 47,6
86 
-0.1(-0.3 to 0.04) 43,5
37 
-0.1 (-0.3 to 0.05) -0.1(-0.3 to 0.06) 
Model 1: adjusted for  age, sex; 
Model 2: further adjusted for season of blood draw, smoking status and pack-years, education, employment and alcohol consumption.  
Model 2*: further adjusted for air pollution (a for PM10, b for NO2), or daytime noise, based on Model 2.  
BOLD indicates where significance level <0.05. 
 
Supplement-3   
Table S3.1 Sensitivity analyses based on Model2  
Daytime Noise  %changes (95%CI) 
 M2 M2+BMI M2+long-term 
health  
long residency 
only 
hsCRP<10 
mg/L only 
HsCRP 1.1(0.02 to 
2.2) 
1.8 (0.8 to 
2.8) 
1.3 (0.2 to 2.4) 1.0 (-0.5 to 2.4) 0.9 (-0.1 to 
1.8) 
Total 
cholesterol 
-0.1 (-0.2 to 
0.1) 
0 (-0.2 to 0.2) 0.03 (-0.1 to 
0.2) 
0.1(-0.2 to 0.3)  
Triglycerides 0.7 (0.3 to 1.0 (0.6 to 0.7 (0.3 to 1.2) 0.4 (-0.1 to 1.0)  
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1.1) 1.4) 
HDL 
cholesterol 
0.5 (0.3 to 
0.7) 
0.3 (0.1 to 
0.5) 
0.4(0.2 to 0.6) 0.2 (-0.1 to 0.5)  
Fasting 
glucose 
0.2 (0.1 to 
0.3) 
0.3 (0.2 to 
0.4) 
0.2(0.1 to 0.4) 0.3 (0.2 to 0.5)  
HbA1c -0.1(-0.1 to 
0.05) 
0% (-0.1 to 
0.1) 
-0.1(-0.1 to 0.1) -0.1 (-0.2 to 
0.1) 
 
      
PM10  %changes (95%CI) 
 M2 M2+BMI M2+long-term 
health  
long residency 
only 
hsCRP<10 
mg/L only 
HsCRP 1.4 (0.1 to 
2.7) 
2.6 (1.3 to 
3.8) 
1.9 (0.5 to 3.3) 2.0 (0.2 to 3.9) 1.0 (-0.1 to 
2.2) 
Total 
cholesterol 
-0.1 (-0.3 to 
0.05) 
-0.1 (-0.3 to 
0.1) 
-0.1 (-0.3 to 
0.1) 
0.04 (-0.2 to 
0.3) 
 
Triglycerides 1.9 (1.5 to 
2.4) 
2.4 (1.9 to 
2.8) 
1.9 (1.4 to 2.4) 2.7 (2.0 to 3.4)  
HDL 
cholesterol 
0.2 (-0.1 to 
0.4) 
-0.1 (-0.3 to 
0.1) 
0.1 (-0.1 to 0.4) -0.5 (-0.8 to -
0.1) 
 
Fasting 
glucose 
0.6 (0.4 to 
0.7) 
0.6 (0.5 to 
0.7) 
0.5 (0.3 to 0.6) 0.7 (0.5 to 1.0)  
HbA1c -0.1(-0.2 to 
0.1) 
0.01 (-0.1 to 
0.1) 
-0.1 (-0.2 to 
0.1) 
0 (-0.2 to 0.2)  
      
NO2  %changes (95%CI) 
 M2 M2+BMI M2+long-term 
health  
long residency 
only 
hsCRP<10 
mg/L only 
HsCRP 1.9 (0.5 to 
3.3) 
3.9 (2.6 to 
5.3) 
2.2 (0.7 to 3.7) 2.3 (0.3 to 4.3) 1.8 (0.5 to 3.1) 
Total 
cholesterol 
-0.1 (-0.3 to 
0.1) 
-0.1 (-0.2 to 
0.2) 
-0.1 (-0.2 to 
0.2) 
0.3 (0 to 0.6)  
Triglycerides 2.2 (1.6 to 
2.7) 
2.9 (2.4 to 
3.4) 
2.0 (1.5 to 2.6) 2.9 (2.1 to 3.7)  
HDL 
cholesterol 
0.5 (0.3 to 
0.8) 
0.1 (-0.1 to 
0.4) 
0.5 (0.3 to 0.8) -0.1 (-0.4 to 
0.3) 
 
Fasting 
glucose 
0.6 (0.4 to 
0.8) 
0.7 (0.6 to 
0.9) 
0.5 (0.3 to 0.6) 0.8 (0.6 to 1.1)  
HbA1c -0.1 (-0.3 to 
0.05) 
0 (-0.2 to 0.1) -0.1 (-0.3 to 
0.02) 
-0.1 (-0.4 to 
0.1) 
 
Model 2: further adjusted for season of blood draw, smoking status and pack-years, education, employment and alcohol consumption. Lday: 
daytime noise; Long-term health: ever-had hypertension and diabetes IQR for daytime noise, PM10 , NO2 was 5.1 dB(A) ,2.0 and 7.4 µg/m
3 
for analyses of hsCRP and lipids; IQR for daytime noise, PM10 , NO2 was 4.2 dB(A), 2.4 and 8.8 µg/m
3 for analyses of fasting glucose. 
 
Supplement-4  
Table S4.1 Categorical noise estimates (% changes, 95%CI) in the main analyses Model 2 
hsCRP, mg/L  Model2 Model2+NO2 Model2+PM10 
Lday, dB(A) N       
<55 40,577 1 1 1 
55-60 10,972 0.1                               
(-2.2 to 2.5) 
-0.7                                   
(-3.3 to 2.0) 
-0.4                           
(-3.0 to 2.3) 
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>=60 4,381 4.2                         
(0.6 to 7.8) 
2.6                                    
(-1.3 to 6.7) 
3.4                          
(-0.5 to 7.5) 
 
Total 
cholesterol, 
mmol/L 
    
Lday, dB(A) N    
<55 56,437 1 1 1 
55-60 17,976 0.004                        
(-0.3 to 0.3) 
0.1                          
(-0.3 to 0.5) 
0.1                        
(-0. 2 to 0.5) 
>=60 7,177 -0.2                      
(-0.7 to 0.3) 
-0. 1                             
(-0.6 to 0.5) 
-0.1                      
(-0.5 to 0.5) 
 
HDL 
cholesterol, 
mmol/L 
    
Lday, dB(A) N    
<55 56,437 1 1 1 
55-60 17,976 0.8                     
(0.4 to 1.3) 
0.5                         
(0.1 to 1.0) 
0.7                      
(0.2 to 1.2) 
>=60 7,177 1.2                   
(0.6 to 1.8) 
0.9                             
(0.2 to 1.6) 
1.2                     
(0.5 to 1.9) 
 
 
Triglycerides, 
mmol/L 
    
Lday, dB(A) N    
<55 56,630 1 1 1 
55-60 17,990 0.04                        
(-0.8 to 0.9) 
-0.4                            
(-1.3 to 0.6) 
-0.2                           
(-1.2 to 0.7) 
>=60 7,179 1.9                            
(0.6 to 3.1) 
0.3                              
(-1.1 to 1.7) 
0.6                             
(-0.8 to 1.9) 
 
Fasting glucose, 
mmol/L 
    
Lday, dB(A) N    
<55 38,984 1 1 1 
55-60 16,903 0.1                         
(-0.1 to 0.3) 
0.04                               
(-0.2 to 0.3) 
0.1                                 
(-0.2 to 0.3) 
>=60 6,878 0.6                         
(0.3 to 0.9) 
0.4                              
(0.01 to 0.7) 
0.4                               
(0. 1 to 0.8) 
 
HbA1c, 
mmol/mol 
    
Lday, dB(A) N    
31 
 
<55 31,464 1 1 1 
55-60 13,741 -0.1                          
(-0.2 to 0.2) 
0.05                               
(-0.2 to 0.3) 
0.01                                
(-0.2 to 0.2) 
>=60 5,709 -0.1                          
(-0.4 to 0.2) 
0.1                             
(-0.2 to 0.5) 
0.05                               
(-0.3 to 0.4) 
Bold indicates where significant level<0.05 ; Model 2 adjusted for cohort (pooled analyses only), age, sex, education, employment status, 
smoking status, smoking pack-years, alcohol consumption.; Lday: daytime noiseIQR for daytime noise and PM10 was 5.1 dB(A) and 2.0 
µg/m3 for analyses of hsCRP and triglycerides; IQR for daytime noise and PM10 was 4.2 dB(A) and 2.4 µg/m
3 for analyses of fasting 
glucose.  
 
Supplement-5 cohort-specific results (%changes per IQR, 95%CI) and meta-analysis for 
HsCRP and blood lipids: results based on Model2.   
Daytime noise     
 HUNT3 Lifelines Pooled  
(meta-analysis) 
Pooled  
(DataSHIEL
D) 
hsCRP 1.8 (-0.5 to 4.0) 0.4 (-0.7 to 1.6) 0.7 (-0.3 to 1.7) 1.1 (0.02 to 
2.2) 
Total cholesterol -0.1 (-0.5 to 0.3) 0.03 (-0.1 to 0.2) 0 (-0.1 to 0.2) -0.1 (-0.2 to 
0.1) 
Triglycerides  0.1 (-1.0 to 1.1) 0.8 (0.4 to 1.2) 0.7 (0.3 to 1.1) 0.7 (0.3 to 
1.1) 
HDL cholesterol 0 (-0.5 to 0.4) 0.5 (0.3 to 0.7) 0.5 (0.3 to 0.7) 0.5 (0.3 to 
0.7) 
     
PM10     
 HUNT3 Lifelines Pooled  
hsCRP 2.7 (0.2 to 5.3) 0.4 (-1.4 to 2.1) 1.1 (-0.3 to 2.5) 1.4 (0.1 to 
2.7) 
Total cholesterol -0.1 (-0.5 to 0.3) 0.1 (-0.1 to 0.3) 0.1(-0.1 to 0.3) -0.1 (-0.3 
to0.05) 
Triglycerides  0.9 (-0.2 to 2.1) 2.7 (2.1 to 3.3) 2.3 (1.8 to 2.8) 1.9 (1.5 to 
2.4) 
HDL cholesterol 0.3 (-0.2 to 0.9) 0.2 (-0.1 to 0.5) 0.2 (0 to 0.5) 0.2 (-0.1 to 
0.4) 
     
NO2     
 HUNT3 Lifelines Pooled  
hsCRP 1.4 (-1.0 to 3.8) 1.4 (-0.5 to 3.2) 1.4 (-0.1 to 2.8) 1.9 (0.5 to 
3.3) 
Total cholesterol -0.1 (-0.5 to 0.3) 0.2 (0.01 to 0.5) 0.2 (0 to 0.4) -0.1 (-0.3 to 
0.1) 
Triglycerides  0.3 (-0.7 to 1.4) 3.1 (2.5 to 3.8) 2.4 (1.8 to 2.9) 2.2 (1.6 to 
2.7) 
HDL cholesterol 0.5 (0 to 1.0) 0.6 (0.3 to 0.9) 0.6 (0.3 to 0.8) 0.5 (0.3 to 
0.8) 
 
 
 
